Cargando…

Early Fesoterodine Fumarate Administration Prevents Neurogenic Detrusor Overactivity in a Spinal Cord Transected Rat Model

BACKGROUND: In spinal cord injury, onset of detrusor overactivity (DO) is detrimental for quality of life (incontinence) and renal risk. Prevention has only been achieved with complex sophisticated electrical neuromodulation techniques. PURPOSE: To assess the efficacy of early fesoterodine fumarate...

Descripción completa

Detalles Bibliográficos
Autores principales: Biardeau, Xavier, Przydacz, Mikolaj, Aharony, Shachar, Loutochin, George, Campeau, Lysanne, Kyheng, Maeva, Corcos, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217950/
https://www.ncbi.nlm.nih.gov/pubmed/28060912
http://dx.doi.org/10.1371/journal.pone.0169694
_version_ 1782492181843410944
author Biardeau, Xavier
Przydacz, Mikolaj
Aharony, Shachar
Loutochin, George
Campeau, Lysanne
Kyheng, Maeva
Corcos, Jacques
author_facet Biardeau, Xavier
Przydacz, Mikolaj
Aharony, Shachar
Loutochin, George
Campeau, Lysanne
Kyheng, Maeva
Corcos, Jacques
author_sort Biardeau, Xavier
collection PubMed
description BACKGROUND: In spinal cord injury, onset of detrusor overactivity (DO) is detrimental for quality of life (incontinence) and renal risk. Prevention has only been achieved with complex sophisticated electrical neuromodulation techniques. PURPOSE: To assess the efficacy of early fesoterodine fumarate (FF) administration in preventing bladder overactivity in a spinal cord transected (SCT) rat model. METHODS: 33 Sprague-Dawley rats were allocated to 6 groups–Group 1: 3 normal controls; Group 2: 6 SCT controls; Group 3: 6 SCT rats + FF 0.18 mg/kg/d; Group 4: 6 SCT rats + FF 0.12 mg/kg/d; Group 5: 6 SCT rats + FF 0.18 mg/kg/d + 72-h wash-out period; Group 6: 6 SCT rats + FF 0.12 mg/kg/d + 72-h wash-out period. SCT was performed at T10. FF was continuously administered. Cystometry was undertaken 6 weeks after SCT in awake rats recording intermicturition pressure (IMP), baseline pressure, threshold pressure (Pthres) and maximum pressure (Pmax). Normal controls and SCT controls were initially compared using the Mann-Whitney U tests in order to confirm the SCT effect on cystometric parameters. The comparisons in cystometric and metabolic cage parameters between SCT controls and treated rats were done using post-hoc Dunn’s tests for Kruskal-Wallis analysis. Statistical testing was conducted at the two-tailed α-level of 0.05. RESULTS: Pressure parameters were significantly higher in SCT control group compared to normal controls. Six weeks after SCT, IMP was significantly lower in low dose treated group than in SCT controls. Pmax was significantly lower in 3 treated groups compared to SCT controls. Pthres was significantly lower in full time treated groups than in SCT controls. CONCLUSION: Early administration of FF modulates bladder overactivity in a SCT rat model. Whereas short-term prevention has been demonstrated, the long-term should be further analyzed. Clinical application of these results should confirm this finding through randomized research protocols.
format Online
Article
Text
id pubmed-5217950
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-52179502017-01-19 Early Fesoterodine Fumarate Administration Prevents Neurogenic Detrusor Overactivity in a Spinal Cord Transected Rat Model Biardeau, Xavier Przydacz, Mikolaj Aharony, Shachar Loutochin, George Campeau, Lysanne Kyheng, Maeva Corcos, Jacques PLoS One Research Article BACKGROUND: In spinal cord injury, onset of detrusor overactivity (DO) is detrimental for quality of life (incontinence) and renal risk. Prevention has only been achieved with complex sophisticated electrical neuromodulation techniques. PURPOSE: To assess the efficacy of early fesoterodine fumarate (FF) administration in preventing bladder overactivity in a spinal cord transected (SCT) rat model. METHODS: 33 Sprague-Dawley rats were allocated to 6 groups–Group 1: 3 normal controls; Group 2: 6 SCT controls; Group 3: 6 SCT rats + FF 0.18 mg/kg/d; Group 4: 6 SCT rats + FF 0.12 mg/kg/d; Group 5: 6 SCT rats + FF 0.18 mg/kg/d + 72-h wash-out period; Group 6: 6 SCT rats + FF 0.12 mg/kg/d + 72-h wash-out period. SCT was performed at T10. FF was continuously administered. Cystometry was undertaken 6 weeks after SCT in awake rats recording intermicturition pressure (IMP), baseline pressure, threshold pressure (Pthres) and maximum pressure (Pmax). Normal controls and SCT controls were initially compared using the Mann-Whitney U tests in order to confirm the SCT effect on cystometric parameters. The comparisons in cystometric and metabolic cage parameters between SCT controls and treated rats were done using post-hoc Dunn’s tests for Kruskal-Wallis analysis. Statistical testing was conducted at the two-tailed α-level of 0.05. RESULTS: Pressure parameters were significantly higher in SCT control group compared to normal controls. Six weeks after SCT, IMP was significantly lower in low dose treated group than in SCT controls. Pmax was significantly lower in 3 treated groups compared to SCT controls. Pthres was significantly lower in full time treated groups than in SCT controls. CONCLUSION: Early administration of FF modulates bladder overactivity in a SCT rat model. Whereas short-term prevention has been demonstrated, the long-term should be further analyzed. Clinical application of these results should confirm this finding through randomized research protocols. Public Library of Science 2017-01-06 /pmc/articles/PMC5217950/ /pubmed/28060912 http://dx.doi.org/10.1371/journal.pone.0169694 Text en © 2017 Biardeau et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Biardeau, Xavier
Przydacz, Mikolaj
Aharony, Shachar
Loutochin, George
Campeau, Lysanne
Kyheng, Maeva
Corcos, Jacques
Early Fesoterodine Fumarate Administration Prevents Neurogenic Detrusor Overactivity in a Spinal Cord Transected Rat Model
title Early Fesoterodine Fumarate Administration Prevents Neurogenic Detrusor Overactivity in a Spinal Cord Transected Rat Model
title_full Early Fesoterodine Fumarate Administration Prevents Neurogenic Detrusor Overactivity in a Spinal Cord Transected Rat Model
title_fullStr Early Fesoterodine Fumarate Administration Prevents Neurogenic Detrusor Overactivity in a Spinal Cord Transected Rat Model
title_full_unstemmed Early Fesoterodine Fumarate Administration Prevents Neurogenic Detrusor Overactivity in a Spinal Cord Transected Rat Model
title_short Early Fesoterodine Fumarate Administration Prevents Neurogenic Detrusor Overactivity in a Spinal Cord Transected Rat Model
title_sort early fesoterodine fumarate administration prevents neurogenic detrusor overactivity in a spinal cord transected rat model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217950/
https://www.ncbi.nlm.nih.gov/pubmed/28060912
http://dx.doi.org/10.1371/journal.pone.0169694
work_keys_str_mv AT biardeauxavier earlyfesoterodinefumarateadministrationpreventsneurogenicdetrusoroveractivityinaspinalcordtransectedratmodel
AT przydaczmikolaj earlyfesoterodinefumarateadministrationpreventsneurogenicdetrusoroveractivityinaspinalcordtransectedratmodel
AT aharonyshachar earlyfesoterodinefumarateadministrationpreventsneurogenicdetrusoroveractivityinaspinalcordtransectedratmodel
AT loutochingeorge earlyfesoterodinefumarateadministrationpreventsneurogenicdetrusoroveractivityinaspinalcordtransectedratmodel
AT campeaulysanne earlyfesoterodinefumarateadministrationpreventsneurogenicdetrusoroveractivityinaspinalcordtransectedratmodel
AT kyhengmaeva earlyfesoterodinefumarateadministrationpreventsneurogenicdetrusoroveractivityinaspinalcordtransectedratmodel
AT corcosjacques earlyfesoterodinefumarateadministrationpreventsneurogenicdetrusoroveractivityinaspinalcordtransectedratmodel